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The preeminent science awards of CDC/ATSDR, inaugurated 
in 1986, are named in honor of Charles C. Shepard, MD, the 
internationally recognized microbiologist who was chief of the 
Leprosy and Rickettsia Branch at CDC for more than 30 years, until 
his death on February 18, 1985.
Charles Carter Shepard was born in Ord, Nebraska, on  
December 18, 1914. He attended Stanford University (1932–1935) 
and then transferred to Northwestern University, where he received 
BS, MS, and MD degrees. In 1941, he joined the Commissioned 
Corps of the Public Health Service. From 1942 through 1948, he 
worked at the National Institutes of Health (NIH) in Bethesda, 
Maryland.
While on sabbatical during 1948–1949, he worked in the laboratory 
of Arne Tiselius in Uppsala, Sweden, and learned the new physical 
separation techniques that would revolutionize immunology and 
biochemistry. He returned to Bethesda for a year before moving to 
the Rocky Mountain Laboratory, National Institute of Allergy and 
Infectious Diseases, NIH, in Hamilton, Montana, to study various 
pathogenic bacteria and their phages at the biochemical and 
ultrastructural levels. In 1953, he came to CDC, where he continued 
his outstanding work with rickettsiae and began his distinguished 
and definitive experiments with mycobacteria, which resulted in the 
cultivation of the leprosy bacillus, Mycobacterium leprae, in mice. 
His landmark article, “The Experimental Disease that Follows the 
Injection of Human Leprosy Bacilli into Foot-Pads of Mice” (Journal 
of Experimental Medicine 1960;112:445–454), is still considered a 
classic in microbiology. His achievement made possible the large-
scale evaluation of antibiotic efficacy and reduced testing time from 
several years to only months. It also paved the way for leprosy 
vaccine studies.
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Dr. Shepard made significant early contributions to the diagnosis, 
natural history, and epidemiology of Rocky Mountain spotted fever; 
Q fever; and scrub, murine, and epidemic typhus. He was also 
co-discoverer (with Joseph McDade) of the Legionnaires’ disease 
bacterium (Legionella pneumophila) after the now famous outbreak 
of virulent pneumonia in Philadelphia in 1976.
Dr. Shepard received numerous awards, among them the Gorgas 
Medal (1962), the Kimble Methodology Award (1962), the Philip 
R. Edwards Award (1964), the World Leprosy Day Award (1970), 
and the first CDC Medal of Excellence (1977). He also received the 
HEW Distinguished Service Medal (1978), the Raol Folleraux Award 
(1978), and the Richard and Hinda Rosenthal Award (1979). He was 
active in multiple professional organizations, including the Armed 
Forces Epidemiologic Board Commission on Rickettsial Diseases; the 
WHO Immunology of Leprosy Program; the WHO Advisory Panel 
on Leprosy; the Heiser Program for Research in Leprosy; and the 
Leprosy Research Council, which he chaired. He was also involved 
in many editorial activities, having served on the board of directors 
of the International Journal of Leprosy and as a frequent reviewer 
for numerous prestigious journals.
Although Dr. Shepard’s contributions to science and public health 
were prodigious, perhaps his greatest legacy is the influence he 
has had on the CDC scientists who have followed in his footsteps 
and have continued to find inspiration in the scientific integrity and 
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John E. Wennberg, MD, MPH
Founder and Director Emeritus
The Dartmouth Institute for Health Policy and Clinical Practice
Dr. John Wennberg is the Peggy Y. Thomson Professor (chair) in the 
Evaluative Clinical Sciences and founder and director emeritus of The 
Dartmouth Institute for Health Policy and Clinical Practice. He is also 
the founding editor of The Dartmouth Atlas of Health Care, which 
examines the patterns of medical resource use in the United States. 
Dr. Wennberg has been a professor in the Department of Community 
and Family Medicine since 1980 and in the Department of Medicine 
since 1989. He is a member of the Institute of Medicine of the National 
Academy of Sciences and the Johns Hopkins University Society of 
Scholars. He has received numerous awards, including the Institute of 
Medicine’s 2008 Gustav O. Lienhard Award, the Association for Health 
Services Research’s Distinguished Investigator Award, the Richard and 
Hinda Rosenthal Foundation Award in Clinical Medicine, and the Baxter 
Foundation’s Health Services Research Prize. 
Dr. Wennberg and colleague Alan Gittelsohn developed a strategy 
for studying the use of health resources that revealed unwarranted 
variations in local and regional health care markets, much of which 
appeared linked to the distribution of resources and to differences in 
local medical opinion. 
Dr. Wennberg and his colleagues undertook a series of studies designed 
to reduce scientific uncertainty, mainly in the area of prostate disease 
(in which surgical procedures had been shown to vary by a factor 
of three or more among neighboring regions). Efforts to clarify the 
outcomes and the theoretical basis for undertaking prostate surgery led 
to awareness of the importance of patient preference in the choice of 
treatment and to studies involving patients as participants in treatment 
choice. Dr. Wennberg’s recent work has focused on documenting and 





Nominated by the Centers for Disease Control and Prevention and the 
Agency for Toxic Substances and Disease Registry  
(CDC/ATSDR) for the 2013 Charles C. Shepard Science Awards
The nominated articles were judged on scientific merit and the 
significance of their effect on the mission of CDC/ATSDR. Following is a 
complete citation and brief description of each article, listed by category 
and in alphabetical order by the first author’s last name.
Assessment
Michael D. Attfield, Patricia L. Schleiff, Jay H. Lubin, Aaron Blair, Patricia 
A. Stewart, Roel Vermeulen, Joseph B. Coble, and Debra T. Silverman
The Diesel Exhaust in Miners Study: A Cohort Mortality Study 
with Emphasis on Lung Cancer
Journal of the National Cancer Institute 2012;104(11):1–15
This was the first study to calculate diesel engine exhaust exposure 
for each worker in the study. Diesel exhaust consists of hundreds of 
chemicals and gases, many of which can cause cancer. The authors 
measured “elemental carbon,” now considered the best substitute for 
diesel exhaust levels.
⧿
Danielle E. Buttke, Kanta Sircar, and Colleen Martin
Exposures to Endocrine-Disrupting Chemicals and Age of 
Menarche in Adolescent Girls in NHANES (2003–2008)
Environmental Health Perspectives 2012;120(11):1613–1618
This is the first study to show a link between exposures to chemicals 
that disrupt the endocrine system and increasingly earlier first menstrual 
cycles in the U.S. population. Laboratory studies have shown that some 
endocrine system disruptors can impair cellular function, and people 
are exposed to many of these chemical compounds in the environment.
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William M. Callaghan, Andreea A. Creanga, and Elena V. Kuklina
Severe Maternal Morbidity among Delivery and Postpartum 
Hospitalizations in the United States
The American College of Obstetricians and Gynecologists 
2012;120(5):1029–1036
The authors propose an easy-to-use indicator of severe maternal 
morbidity that can be used by hospitals, perinatal regions, and states for 
surveillance and quality improvement efforts. Further, the indicator can 
be used at the national level to track severe pregnancy complications.
⧿
Adolfo Correa, Suzanne M. Gilboa, Lorenzo D. Botto, Cynthia A.  
Moore, Charlotte A. Hobbs, Mario A. Cleves, Tiffany J. Riehle-Colarusso, 
D. Kim Waller, and E. Albert Reece for the National Birth Defects 
Prevention Study
Lack of Periconceptional Vitamins or Supplements that Contain 
Folic Acid and Diabetes Mellitus-Associated Birth Defects
American Journal of Obstetrics and Gynecology 2012;206(3):218.e1–e13
This is only the second study in humans to suggest that vitamins 
containing folic acid may decrease the harmful effects of diabetes 
on pregnancy. The analysis revealed a pattern of associations across 
most birth defects among women who did not report taking vitamins 
containing folic acid.
⧿
Tracy Dalton, Peter Cegielski, Somsak Akksilp, Luis Asencios, Janice 
Campos Caoili, Sang-Nae Cho, Vladislav V. Erokhin, Julia Ershova,  
Ma Tarcela Gler, Boris Y. Kazennyy, Hee Jin Kim, Kai Kliiman, Ekaterina 
Kurbatova, Charlotte Kvasnovsky, Vaira Leimane, Martie van der Walt, 
Laura E. Via, Grigory V. Volchenkov, Martin A. Yagui, Hyungseok Kang, 
and the Global PETTS Investigators
Prevalence of and Risk Factors for Resistance to Second-Line 
Drugs in People with Multidrug-Resistant Tuberculosis in 
Eight Countries: A Prospective Cohort Study
The Lancet 2012;380(9851):1406–1417
This study examined drug resistance in 1,278 patients starting treatment 
for tuberculosis. Demographic and clinical data were collected and 
monitored for accuracy, allowing an analysis of risk factors associated 
with resistance to second-line drugs used for treatment.
9
Fatimah S. Dawood, A. Danielle Iuliano, Carrie Reed, Martin I. Meltzer, 
David K. Shay, Po-Yung Cheng, Don Bandaranayake, Robert F. Breiman, 
W. Abdullah Brooks, Philippe Buchy, Daniel R. Feikin, Karen B. Fowler, 
Aubree Gordon, Nguyen Tran Hien, Peter Horby, Q. Sue Huang, Mark 
A. Katz, Anand Krishnan, Renu Lal, Joel M. Montgomery, Kåre Mølbak, 
Richard Pebody, Anne M. Presanis, Hugo Razuri, Anneke Steens, Yeny 
O. Tinoco, Jacco Wallinga, Hongjie Yu, Sirenda Vong, Joseph Bresee, 
and Marc-Alain Widdowson
Estimated Global Mortality Associated with the First 
12 Months of 2009 Pandemic Influenza A H1N1 Virus 
Circulation: A Modelling Study
The Lancet Infectious Diseases 2012;12(9):687–695
This paper reports the first mortality estimate of the 2009 H1N1 
pandemic. The authors use data from influenza surveillance and special 
studies to estimate attack rates and fatality ratios by age group. Sites 
contributing data to the paper represent 13 high-, middle-, and low-
income countries.
⧿
Carrie A. Dooyema, Antonio Neri, Yi-Chun Lo, James Durant,  
Paul I. Dargan, Todd Swarthout, Oladayo Biya, Saheed O. Gidado, 
Suleiman Haladu, Nasir Sani-Gwarzo, Patrick M. Nguku, Henry Akpan, 
Sa’ad Idris, Abdullahi M. Bashir, and Mary Jean Brown
Outbreak of Fatal Childhood Lead Poisoning Related to 
Artisanal Gold Mining in Northwestern Nigeria, 2010
Environmental Health Perspectives 2012;120(4):600–607
The authors investigated the effects of gold mining activities on high 
child mortality rates and an outbreak of childhood lead poisoning in 
rural northwestern Nigeria. They also examined emergency methods of 
removing heavy metals from the bloodstream. Most of the illnesses and 
deaths occurred in children under 5 years of age.
⧿
Deborah Dowell, Lin H. Tian, Jeffrey A. Stover, Jennifer A. Donnelly, 
Summer Martins, Emily J. Erbelding, Raul Pino, Hillard Weinstock, and 
Lori M. Newman
Changes in Fluoroquinolone Use for Gonorrhea Following 
Publication of Revised Treatment Guidelines
Research and Practice 2012;102(1):148–155
This study used an enhanced surveillance system to evaluate the impact 
of revised CDC guidelines on fluoroquinolone use for gonorrhea. The 
authors used an interrupted time series design to evaluate whether the 
guidelines significantly affected prescribing behavior over time.
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Xiangming Fang, Derek S. Brown, Curtis S. Florence, and James A. Mercy
The Economic Burden of Child Maltreatment in the United 
States and Implications for Prevention
Child Abuse & Neglect 2012;36(2):156–165
The authors developed an improved method for estimating the 
economic burden of child maltreatment, which, conservatively, is 
estimated to be at least $210,000 per victim. This cost per child is 
comparable to the economic burden of other public health problems 
such as stroke and type 2 diabetes.
⧿
Giuseppina Imperatore, James P. Boyle, Theodore J. Thompson, Doug 
Case, Dana Dabelea, Richard F. Hamman, Jean M. Lawrence, Angela D. 
Liese, Lenna L. Liu, Elizabeth J. Mayer-Davis, Beatriz L. Rodriguez, and 
Debra Standiford for the Search for Diabetes in Youth Study Group
Projections of Type 1 and Type 2 Diabetes Burden in the U.S. 
Population Aged <20 Years through 2050: Dynamic Modeling 
of Incidence, Mortality, and Population Growth
Diabetes Care 2012;35(12):2515–2520
This is the first paper to project the future burden of diabetes in youth. 
Although projections of diabetes prevalence in older people have been 
published, a consideration of youth requires more sophisticated models. 
In addition, this is the first projection of diabetes burden to separate 
types 1 and 2 diabetes.
⧿
Adam J. Langer, Tracy Ayers, Julian Grass, Michael Lynch,  
Frederick J. Angulo, and Barbara E. Mahon
Nonpasteurized Dairy Products, Disease Outbreaks, and  
State Laws—United States, 1993–2006
Emerging Infectious Diseases 2012;18(3):385–391
This paper compares foodborne illness data on the sale of 
nonpasteurized milk products to examine the burden of dairy-
associated illnesses and the association of state laws with risk of 
outbreaks linked to these products from 1993 through 2006. The 
evidence suggests states that do not allow the sale of raw dairy 
products have substantially lower risk of outbreaks. 
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Chaoyang Li, Earl S. Ford, Guixiang Zhao, James Tsai, Lina S. Balluz, 
and Wayne H. Giles
Trends of Insulin Use among U.S. Adults with Type 2 
Diabetes: The Behavioral Risk Factor Surveillance System, 
1995–2007
Journal of Diabetes and Its Complications 2012;26(1):17–22
This is the first study to examine trends among adults with type 2 
diabetes who used insulin, based on large population-based samples of 
U.S. adults aged 40 years or older who participated in the Behavioral 
Risk Factor Surveillance System in 1995 and 2007.
⧿
Ruowei Li, Joselito Magadia, Sara B. Fein, and  
Laurence M. Grummer-Strawn
Risk of Bottle-Feeding for Rapid Weight Gain  
during the First Year of Life
Archives of Pediatrics and Adolescent Medicine 2012;166(5):431–436
This study explored the mechanism by which infant weight gain 
varies during the first year. Findings suggest bottle-feeding, regardless 
of formula type, might cause infants to gain weight faster than 
breastfeeding because bottle-fed infants may gradually lose the ability 
to regulate their calorie consumption using the internal feeding cues of 
hunger and satisfaction. 
⧿
Sara E. Luckhaupt, Dennis Deapen, Rosemary Cress, Pam Schumacher, 
Rui Shen, and Geoffrey M. Calvert 
Leukemia among Male Construction Workers in California, 
1988–2007
Leukemia & Lymphoma 2012;53(11):2228–2236
Many small studies point to increases in the incidence of leukemia 
among construction workers, but these data are fragmented and the 
results inconsistent. This exhaustive study examined associations 
between construction occupations and the four major subtypes of 
leukemia. It also permitted evaluation of disparities among racial and 
ethnic groups.
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Kathleen N. Ly, Jian Xing, R. Monina Klevens, Ruth B. Jiles,  
John W. Ward, and Scott D. Holmberg
The Increasing Burden of Mortality from Viral Hepatitis in 
the United States between 1999 and 2007
Annals of Internal Medicine 2012;156(4):271–278
Using death certificate data from more than 22 million records, the 
authors examined trends in deaths from hepatitis B and C virus and HIV 
infections to predict the health and economic consequences of viral 
hepatitis. Annual deaths from hepatitis C now exceed those from HIV, 
and deaths from hepatitis B and C are concentrated among middle-aged 
persons.
⧿
Catherine A. Okoro, Tara W. Strine, Paul I. Eke, Satvinder S. Dhingra, 
and Lina S. Balluz
The Association between Depression and Anxiety and Use of 
Oral Health Services and Tooth Loss
Community Dentistry and Oral Epidemiology 2012;40(2):134–144
Study findings suggest that disparities in the prevalence of use of 
oral health services and tooth loss exist among people suffering 
from depression and anxiety. These findings have strong implications 
given that the onset of many psychiatric disorders occurs early in life, 
increasing their potential to impair oral health over time. 
⧿
Ju-Hyeong Park, Kay Kreiss, and Jean M. Cox-Ganser
Rhinosinusitis and Mold as Risk Factors for Asthma 
Symptoms in Occupants of a Water-Damaged Building
Indoor Air 2012;22(5):396–404
The authors used a longitudinal approach to determine that building-
related rhinosinusitis and mold exposure were risk factors for building-
related asthma symptoms but not for non-building-related asthma 
symptoms. The implication is that building-related nasal symptoms 
in damp indoor environments imply risk for more serious health 
outcomes.
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Robert M. Park, Leslie T. Stayner, Martin R. Petersen, Melissa Finley-
Couch, Richard Hornung, and Carol Rice
Cadmium and Lung Cancer Mortality Accounting for 
Simultaneous Arsenic Exposure
Occupational and Environmental Medicine 2012;69(5):303–310
The authors separated the effects of mutually confounding exposures 
among smelter employees. Although there was a clear association of 
lung cancer with cadmium exposure, arsenic exposure was a possible 
confounder of the results. The study methods allowed for an analysis of 
the effects of cadmium alone, resulting in strong scientific evidence of 
its cancer-causing effects.
⧿
Lucy A. Peipins, Ashwini Soman, Zahava Berkowitz, and Mary C. White
The Lack of Paid Sick Leave as a Barrier to Cancer Screening 
and Medical Care-Seeking: Results from the National Health 
Interview Survey
BioMed Central 2012; doi: 10.1186/1471-2458-12-520
The lack of sick leave as a barrier to seeking medical care is not 
often analyzed. Factors shown to encourage care-seeking include 
demographic characteristics and having health insurance and usual 
source of care. This study shows that, for workers, paid sick leave 
strongly encourages people to seek medical care. 
⧿
Suzanne E. Powell, Susan Hariri, Martin Steinau, Heidi M. Bauer,  
Nancy M. Bennett, Karen C. Bloch, Linda M. Niccolai, Sean Schafer, 
Elizabeth R. Unger, and Lauri E. Markowitz
Impact of Human Papillomavirus (HPV) Vaccination on HPV 
16/18-Related Prevalence in Precancerous Cervical Lesions
Vaccine 2012;31(1):109–113
This paper evaluated the effect of HPV vaccine on cervical precancers 
(CIN2+) using only case surveillance data without the need for a control 
group. Using laboratory data to look at specific HPV types associated 
with CIN2+ lesions, the results suggest earlier than expected impact on 
HPV 16/18-related CIN2+ lesions in women aged 18–31 years in the 
United States.
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David W. Purcell, Christopher H. Johnson, Amy Lansky, Joseph Prejean, 
Renee Stein, Paul Denning, Zaneta Gau, Hillard Weinstock, John Su, and 
Nicole Crepaz
Estimating the Population Size of Men Who Have Sex with 
Men in the United States to Obtain HIV and Syphilis Rates
Open AIDS Journal 2012;6 (Suppl 1:M6):98–107
The authors used national data on same-sex behavior and applied the 
proportion of men reporting same-sex behavior in the past 5 years to 
U.S. census data to produce a population-size estimate. The estimate 
allowed the authors to calculate the rates for disease metrics and to 
develop rate ratios showing dramatically higher rates of HIV and 
syphilis among men who have sex with men than among other men  
or women. 
⧿
Erin K. Sauber-Schatz, William Sappenfield, Violanda Grigorescu,  
Aniket Kulkarni, Yujia Zhang, Hamisu M. Salihu, Lewis P. Rubin,  
Russell S. Kirby, Denise J. Jamieson, and Maurizio Macaluso
Obesity, Assisted Reproductive Technology, and Early Preterm 
Birth—Florida, 2004–2006
American Journal of Epidemiology 2012; doi: 10.1093/aje/kws155
This study determined that assisted reproductive technology (ART) 
significantly increases the likelihood of early preterm birth among 
women who are overweight before becoming pregnant. Findings also 
suggest healthy weight loss through diet and exercise before pregnancy 
might reduce preterm birth among ART users. 
⧿
Guo-Qing Shi, Wen-Li Huang, Jian Zhang, Hong Zhao, Tao Shen,  
Robert E. Fontaine, Lin Yang, Su Zhao, Bu-Lai Lu, Yue-Bing Wang,  
Lin Ma, Zhao-Xiang Li, Yang Gao, Zhu-Liang Yang, and Guang Zeng 
Clusters of Sudden Unexplained Death Associated with the 
Mushroom, Trogia venenata, in Rural Yunnan Province, China
PLoS One 2012;7(5):1–8 
For years, healthy adult villagers in Yunnan Province, China, would 
collapse during normal activities, lapse into a coma, and die. Since the 
1980s, the cause of these deaths remained unknown. This paper ties 
the sudden unexplained deaths to Trogia venenata, a new species of 
mushroom, discovered during the field investigation of the more recent 
unexplained deaths.
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Irene M. Shui, James Baggs, Manish Patel, Umesh D. Parashar,  
Melisa Rett, Edward A. Belongia, Simon J. Hambidge, Jason M. Glanz, 
Nicola P. Klein, and Eric Weintraub 
Risk of Intussusception Following Administration of a 
Pentavalent Rotavirus Vaccine in U.S. Infants
JAMA 2012;307(6):598–604
Experience with the Rotashield vaccine has alerted public health 
agencies to continue monitoring newer rotavirus vaccines. This study 
examined the risk of intussusception following the administration of 
the rotavirus vaccine in infants. The study found no association with 
intussusception and strengthened the case for continuing the use of the 
rotavirus vaccine.
⧿
Rachel M. Smith, Melissa K. Schaefer, Marion A. Kainer, Matthew Wise, 
Jennie Finks, Joan Duwve, Elizabeth Fontaine, Alvina Chu, Barbara 
Carothers, Amy Reilly, Jay Fiedler, Andrew D. Wiese, Christine Feaster, 
Lex Gibson, Stephanie Griese, Anne Purfield, Angela A. Cleveland, 
Kaitlin Benedict, Julie R. Harris, Mary E. Brandt, Dianna Blau, John 
Jernigan, J. Todd Weber, and Benjamin J. Park for the Multistate Fungal 
Infection Outbreak Response Team
Fungal Infections Associated with Contaminated 
Methylprednisolone Injections—Preliminary Report
The New England Journal of Medicine 2012; doi: 10.1056/NEJMoa1213978
This paper describes how the largest ever series of fungal meningitis 
outbreaks due to mold was contained. In addition to expanding the 
literature and understanding of fungal meningitis, findings of this paper 
could affect the future of compounding pharmacies in the United States. 
⧿
Nancy Sonnenfeld, Stephen R. Pitts, Susan M. Schappert, and  
Sandra L. Decker
Emergency Department Volume and Racial and Ethnic 
Differences in Waiting Times in the United States
Medical Care 2012;50(4):335–341
Black and Hispanic patients have to wait longer to receive care in 
U.S. emergency departments than their white counterparts. Analyzing 
data from the 2007–2008 National Hospital Ambulatory Medical Care 
Survey, this study takes a novel approach to examine racial and ethnic 
disparities in emergency room waiting time. 
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Tarak K. Trivedi, Traci DeSalvo, Lore Lee, Aimee Palumbo, Maria Moll, 
Aaron Curns, Aron J. Hall, Manish Patel, Umesh D. Parashar, and 
Benjamin A. Lopman
Hospitalizations and Mortality Associated with Norovirus 
Outbreaks in Nursing Homes, 2009–2010
JAMA 2012;308(16):1668–1675
Patterns from norovirus outbreaks in nursing homes suggest outbreaks 
may lead to deaths. The authors constructed a retrospective cohort 
of nursing homes with norovirus outbreaks to identify deaths and 
hospitalizations and to identify nursing home characteristics associated 
with death and hospitalization. 
⧿
Quanhe Yang, Mary E. Cogswell, W. Dana Flanders, Yuling Hong, 
Zefeng Zhang, Fleetwood Loustalot, Cathleen Gillespie, Robert Merritt, 
and Frank B. Hu
Trends in Cardiovascular Health Metrics and Associations 
with All-Cause and CVD Mortality among U.S. Adults
JAMA 2012;307(12):1273–1283
Preventing the development of risk factors offers promise for 
cardiovascular health. This study examined the prevalence and trends 
in cardiovascular health data, their associations, and population-
attributable fractions with all-cause and cardiovascular disease  
mortality risk. 
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Data Methods and Study Design
Joseph Y. Abrams, J. R. Copeland, Robert V. Tauxe, Kashmira A. Date, 
Ermias D. Belay, Rajal K. Mody, and Eric D. Mintz
Real-Time Modelling Used for Outbreak Management during 
a Cholera Epidemic, Haiti, 2010–2011
Epidemiology and Infection 2012; doi: 10.1017/S0950268812001793
This paper describes detailed forecasting models in the wake of Haiti’s 
cholera epidemic following the earthquake of January 2010. The data 
generated by four successive models were used by CDC, Haitian 
ministries, and external aid organizations to target needs and supplies 
on a geographical basis, to analyze the gap between estimated and 
existing facilities and supplies, and to fund contracts to temporarily 
expand facilities.
⧿
Zhuo Adam Chen, Kakoli Roy, and Carol A. Gotway Crawford
Obesity Prevention: The Impact of Local Health Departments
Health Services Research 2012; doi: 10.1111/j.1475-6773.2012.01447.x
The role of local health departments in reducing obesity has not yet 
been well-studied. This study is the first to assess the relationship 
between county health department interventions and obesity as 
measured in the Behavioral Risk Factor Surveillance System, CDC’s 
national health surveillance system of chronic disease risk factors and 
health status.
⧿
Jinhua Guan, Hongwei Hsiao, Bruce Bradtmiller, Tsui-Ying Kau, 
Matthew R. Reed, Steven K. Jahns, Josef Loczi, H. Lenora Hardee, and 
Dominic Paul T. Piamonte
U.S. Truck Driver Anthropometric Study and Multivariate 
Anthropometric Models for Cab Designs
Human Factors 2012;54(5):849–871
There is a need to improve ergonomic truck cab designs for safe and 
efficient operation, as there is now a greater diversity among truck 
drivers. Data suggest male drivers have become larger and heavier than 
the U.S. population over the past quarter century. These data will be an 
important resource for future truck cab designs.
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Heather C. Hamner, Sarah C. Tinker, Alina L. Flores, Joe Mulinare,  
Aliki P. Weakland, and Nicole F. Dowling
Modelling Fortification of Corn Masa Flour with Folic Acid 
and the Potential Impact on Mexican American Women with 
Lower Acculturation
Public Health Nutrition 2012; doi: 10.1017/S1368980012004582
Brain and spinal cord defects affect about 3,000 pregnancies per year 
in the United States. Adding folic acid to foods prevents thousands of 
these defects. This study determines if consumption of folic acid could 
increase for Mexican American women if corn masa flour were fortified 
with folic acid.
⧿
Ramal Moonesinghe, Eleanor Fleming, Benedict I. Truman, and  
Hazel D. Dean
Linear and Non-Linear Associations of Gonorrhea Diagnosis 
Rates with Social Determinants of Health
International Journal of Environmental Research and Public Health 
2012;9(9)3149–3165
If health departments can determine local factors that increase 
gonorrhea rates, then programs can be tailored to better control 
gonorrhea’s spread. Using sophisticated surveillance and social data, 
the authors calculated gonorrhea rates for each geographic area and 
analyzed associations between those rates and social determinants of 
health. The authors found that unmarried and minority status strongly 
correlated with gonorrhea diagnosis.
⧿
Latetia V. Moore, Ana V. Diez Roux, and Manuel Franco
Measuring Availability of Healthy Foods: Agreement between 
Directly Measured and Self-Reported Data
American Journal of Epidemiology 2012;175(10):1037–1044
This study demonstrates that people know where healthy foods are 
available in their communities. Telephone surveys used to measure the 
availability of healthy foods can substitute for more direct measures. 
This finding gives researchers options for measuring the food 
environment accurately and at a lower cost.
19
Manish M. Patel, Andrew D. Clark, Colin F. B. Sanderson,  
Jacqueline Tate, and Umesh D. Parashar 
Removing the Age Restrictions for Rotavirus Vaccination:  
A Benefit-Risk Modeling Analysis
PLoS Medicine 2012;9(10):e1001330
To evaluate World Health Organization (WHO) recommendations on 
restricting the rotavirus vaccine on infants, the authors conducted the 
first risk-benefit analysis on the vaccine’s safety and effectiveness for 
infants under 15 weeks old. The study found that removing the age 
restriction would prevent 154 deaths from rotavirus for each death 
caused by the vaccine, prompting a change in WHO recommendations.
⧿
Muhammad Aziz Rahman, Mohammad Jahangir Hossain, Sharmin 
Sultana, Nusrat Homaira, Salah Uddin Khan, Mahmudur Rahman,  
Emily S. Gurley, Pierre E. Rollin, Michael K. Lo, James A. Comer,  
Luis Lowe, Paul A. Rota, Thomas G. Ksiazek, Eben Kenah,  
Yushuf Sharker, and Stephen P. Luby
Date Palm Sap Linked to Nipah Virus Outbreak in 
Bangladesh, 2008
Vector-Borne and Zoonotic Diseases 2012;12(1):65–72
Nipah virus infection is fatal in 70% to 90% of cases in Bangladesh. This 
study confirmed the association between consuming date palm sap 
and Nipah infection. Using infrared photography, bats were observed 
in contact with sap-collecting taps and pots attached to date trees. This 
study provides vital elements of the emerging picture of this zoonotic 
infection originating in bats and infections in humans in Bangladesh.
⧿
Carrie Reed, Matthew Biggerstaff, Lyn Finelli, Lisa M. Koonin,  
Denise Beauvais, Amra Uzicanin, Andrew Plummer, Joe Bresee,  
Stephan C. Redd, and Daniel B. Jernigan
Novel Framework for Assessing Epidemiologic Effects of 
Influenza Epidemics and Pandemics
Emerging Infectious Diseases 2013;19(1):85–91
The authors present an adaptable framework to simplify epidemiologic 
data collection and decision making early in a pandemic. The paper 
also summarizes data on transmission and severity of influenza from 
four modern pandemics and selected influenza seasons after a review 
of literature and historic surveillance data since 1918.
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Matthew E. Wise, Melissa Viray, James J. Sejvar, Paige Lewis, Andrew L. 
Baughman, Walter Connor, Richard Danila, Greg P. Giambrone, Christa 
Hale, Brenna C. Hogan, James I. Meek, Rendi Murphree, John Y. Oh, 
Arthur Reingold, Norisse Tellman, Susan M. Conner, James A. Singleton, 
Peng-Jun Lu, Frank DeStefano, Scott K. Fridkin, Claudia Vellozzi, and 
Oliver W. Morgan
Guillain-Barré Syndrome during the 2009–2010 H1N1 
Influenza Vaccination Campaign: Population-Based 
Surveillance among 45 Million Americans
American Journal of Epidemiology 2012;175(11):1110–1119
The authors found that persons vaccinated for the H1N1 pandemic had 
a higher risk of acquiring Guillain-Barré Syndrome than unvaccinated 
persons; this risk, however, was comparable to some seasonal flu 
vaccines. The study serves as a model for similar real-time surveillance 
associated with urgent interventions.
⧿
Guangyu Zhang, Nathaniel Schenker, Jennifer D. Parker, and Dan Liao
Identifying Implausible Gestational Ages in Preterm Babies 
with Bayesian Mixture Models
Statistics in Medicine 2012; doi: 10.1002/sim.5657
Preterm birth is a leading cause of infant mortality. However, 
inaccurately reported gestational ages can hinder the study of preterm 
birth using birth records. The authors’ work improves the quality of U.S. 
birth data by identifying implausible gestational ages. More accurate 
gestational age data help to better monitor infant health, detect health 
problems, and develop sound public health policies.
⧿
Xiaohui Zhuo, Ping Zhang, Edward W. Gregg, Lawrence Barker,  
Thomas J. Hoerger, Tony Pearson-Clarke, and Ann Albright
A Nationwide Community-Based Lifestyle Program Could 
Delay or Prevent Type 2 Diabetes Cases and Save $5.7 Billion 
in 25 Years
Health Affairs 2012;31(1):50–60
Weight loss and increased physical activity can delay or prevent type 2 
diabetes. However, the economic impact of scaling up this intervention 
to the national level has not been known. This paper provides the 
first verification that a national-scale, intensive effort to prevent type 2 
diabetes would reduce health care costs. 
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Laboratory Science
Harvey J. Alter, Judy A. Mikovits, William M. Switzer, Francis W. Ruscetti, 
Shyh-Ching Lo, Nancy Klimas, Anthony L. Komaroff, Jose G. Montoya, 
Lucinda Bateman, Susan Levine, Daniel Peterson, Bruce Levin, Maureen 
R. Hanson, Afia Genfi, Meera Bhat, HaoQiang Zheng, Richard Wang, 
Bingjie Li, Guo-Chiuan Hung, Li Ling Lee, Stephen Sameroff, Walid 
Heneine, John Coffin, Mady Hornig, and W. Ian Lipkin
A Multicenter Blinded Analysis Indicates No Association  
between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 
and Either Xenotropic Murine Leukemia Virus-Related Virus or 
Polytropic Murine Leukemia Virus
mBio 2012;3(5):e00266-12
Despite contrary scientific consensus, many people believe chronic 
fatigue syndrome is associated with xenotropic murine leukemia virus-
related virus and polytropic murine leukemia virus. In a blind analysis 
of 293 geographically diverse subjects, the authors found no evidence 
associating chronic fatigue syndrome with the leukemia virus infections. 
⧿
Li-Mei Chen, Ola Blixt, James Stevens, Aleksandr S. Lipatov,  
Charles T. Davis, Brian E. Collins, Nancy J. Cox, James C. Paulson,  
and Ruben O. Donis
In Vitro Evolution of H5N1 Avian Influenza Virus toward 
Human-Type Receptor Specificity
Virology 2012;422(1):105–113
As shown during the 2009 H1N1 pandemic, early intervention is 
essential for containing the spread of the disease. Therefore, efforts 
to anticipate the emergence of influenza pandemics, and H5N1 in 
particular, are of the utmost importance. This paper shows specific 
influenza hemagglutinin mutations required for the spread of H5N1 
in ferrets and provides critical markers to assess the risk for human 
transmission.
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Yan S. Ding, Theodore Chou, Shadeed Abdul-Salaam, Bryan Hearn,  
and Clifford H. Watson
Development of a Method to Estimate Mouth-Level  
Benzo[a]pyrene Intake by Filter Analysis
Cancer Epidemiology, Biomarkers & Prevention 2012;21(1):39–44
Cigarette smoke exposes people to many harmful chemicals, and 
Benzo[a]pyrene (BaP) is one of the most potent. There is no direct way 
to estimate exposure to BaP because of difficulties in measuring its 
metabolites in humans. The authors found that discarded cigarette filters 
provide a quick, noninvasive, and accurate route to estimate mouth-
level BaP intake.
⧿
Yen T. Duong, Maofeng Qiu, Anindya K. De, Keisha Jackson, Trudy 
Dobbs, Andrea A. Kim, John N. Nkengasong, and Bharat S. Parekh
Detection of Recent HIV-1 Infection Using a New Limiting-
Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates 
and Avidity Maturation Studies
PLoS One 2012;7(3):e33328
The spread of HIV is driven mostly by recently infected people who 
have a higher viral load and continue high-risk behavior. The authors 
developed a new way to distinguish recent HIV-1 infections from long-
term infections, opening the way for better estimates of the spread 
of HIV-1 infections. The new method can also be applied to other 
infections, such as rubella, measles, and hepatitis.
⧿
E. Brook Goodhew, Jeffrey W. Priest, Delynn M. Moss, Guangming 
Zhong, Beatriz Munoz, Harran Mkocha, Diana L. Martin, Sheila K. West, 
Charlotte Gaydos, and Patrick J. Lammie
CT694 and pgp3 as Serological Tools for Monitoring 
Trachoma Programs
PLoS Neglected Tropical Diseases 2012;6(11):e1873
The bacterium Chlamydia trachomatis causes trachoma, the most 
frequent cause of infectious blindness. Trachoma afflicts millions in 
Africa and Southeast Asia, especially women and children. This paper 
presents a novel way to monitor trachoma programs through serological 
testing. The authors identified two antigens as possible candidates for 
measuring serologic responses to C. trachomatis.
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Jingcheng Li, Jacob Carr, and Christopher Jobes
A Shell-Based Magnetic Field Model for Magnetic Proximity 
Detection Systems
Safety Science 2012;50:463–471
The Mine Safety and Health Administration estimates that about 20% 
of mining-related deaths could be prevented through the use of 
proximity detection technology. The shell-based analytical model that 
NIOSH researchers developed in this study mathematically describes 
the variation of the magnetic fields used in detection equipment. This 
finding has enabled production of more reliable detection systems to 
better protect miners.
⧿
Naomi W. Lucchi, Mitra Poorak, Jenna Oberstaller, Jeremy DeBarry, 
Ganesh Srinivasamoorthy, Ira Goldman, Maniphet Xayavong, Alexandre 
J. da Silva, David S. Peterson, John W. Barnwell, Jessica Kissinger, and 
Venkatachalam Udhayakumar
A New Single-Step PCR Assay for the Detection of the 
Zoonotic Malaria Parasite Plasmodium knowlesi
PLoS One 2012;7(2):e31848
This study marks one of the first times constructing a complete 
gene sequence for a pathogen has led to the development of a new 
diagnostic test. The authors’ work demonstrates the value of the malaria 
parasite genome database. It also points to the promise that future 
targets for diagnostic, pharmaceutical, or vaccine development might 
also be accomplished from a bioinformatics approach. 
⧿
Jane Y. Ma, Robert R. Mercer, Mark Barger, Diane Schwegler-Berry, 
James Scabilloni, Joseph K. Ma, and Vincent Castranova
Induction of Pulmonary Fibrosis by Cerium Oxide 
Nanoparticles
Toxicology and Applied Pharmacology 2012;262(3):255–264
Cerium compounds have been used as a fuel additive to reduce 
emissions, but they are released as cerium oxide nanoparticles, which 
have been criticized as unsafe. The study demonstrates that cerium 
oxide causes pulmonary fibrosis in rats, suggesting it will likely affect 
humans as well. 
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Laura K. McMullan, Scott M. Folk, Aubree J. Kelly, Adam MacNeil, 
Cynthia S. Goldsmith, Maureen G. Metcalfe, Brigid C. Batten,  
César G. Albariño, Sherif R. Zaki, Pierre E. Rollin, William L. Nicholson, 
and Stuart T. Nichol
A New Phlebovirus Associated with Severe Febrile  
Illness in Missouri
The New England Journal of Medicine 2012;367(9):834–841
This paper describes the discovery of a tick-borne virus new to the 
Americas. Analysis of the virus genome revealed a distinct member of 
the phlebovirus genus that the authors named Heartland virus. With 
its identification and genetic sequencing, Heartland virus is now much 
better understood, and strategies to reduce the risks associated with it 
can be developed.
⧿
Connie H. Miller, S. J. Platt, Anne S. Rice, Fiona Kelly, J. Michael Soucie, 
and The Hemophilia Inhibitor Research Study Investigators
Validation of Nijmegen–Bethesda Assay Modifications to 
Allow Inhibitor Measurement during Replacement Therapy 
and Facilitate Inhibitor Surveillance
Journal of Thrombosis and Haemostasis 2012;10(6):1055–1061
Development of inhibitors (antibodies) against clotting factor replacement 
protein is the most significant cause of death among persons with 
hemophilia. The authors used knowledge of antibody characteristics to 
modify a clinical test and make it applicable for national surveillance. It is 
the first test for treatment-related antibodies used for hemophilia patients 
that does not require them to abstain from treatment.
⧿
Rendi Murphree, J. R. Dunn, William Schaffner, and T. F. Jones
La Crosse Encephalitis Surveillance Using Single Versus 
Paired Serologic Testing
Zoonoses and Public Health 2012;59(3):181–183
La Crosse virus (LACV) is the most frequent cause of arboviral 
encephalitis among children. The findings in this study suggest that a 
single serologic test can be used in areas where LACV encephalitis is 
more common. This simplified testing approach can decrease laboratory 
burdens and increase public health workers’ efficiency.
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Linda M. Sargent, Ann F. Hubbs, S. H. Young, Michael L. Kashon, 
Cerasela Z. Dinu, J. L. Salisbury, Stanley A. Benkovic, David T. Lowry,  
A. R. Murray, Elena R. Kisin, Katelyn J. Siegrist, Lori Battelli,  
J. Mastovich, J. L. Sturgeon, Kristin L. Bunker, Anna A. Shvedova,  
and Steven H. Reynolds
Single-Walled Carbon Nanotube-Induced Mitotic Disruption
Mutation Research 2012;745(1–2):28–37
Because of the many emerging commercial applications for carbon 
fibers and their physical similarities to asbestos fibers, respiratory 
exposure to workers is likely to increase. This study assesses the toxicity 
of carbon nanotubes and demonstrates that single-walled tubes disrupt 
cell division and cause errors in the numbers of chromosomes.
⧿
John R. Su, Allan Pillay, Edward W. Hook, Khalil G. Ghanem, William 
Wong, Dawn Jackson, Lewis D. Smith, Elaine Pierce, Susan S. Philip, 
Steven Wilson, Matthew R. Golden, Kimberly A. Workowski, Kai-Hua 
Chi, Deidra D. Parrish, Cheng Y. Chen, and Hillard S. Weinstock
Prevalence of the 23S rRNA A2058G Point Mutation and 
Molecular Subtypes in Treponema pallidum in the United 
States, 2007 to 2009
Sexually Transmitted Diseases 2012;39(10):794–798
Using molecular techniques, this study detected a Treponema pallidum 
mutation associated with syphilis treatment failure and allowed the 
description of T. pallidum subtypes present in different risk populations. 
This paper represents the first study to apply these techniques to 
samples of T. pallidum from sites across the United States and provides 
insight into how to address the disease in these areas.
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Hong Thai, David S. Campo, James Lara, Zoya Dimitrova, Sumathi 
Ramachandran, Guoliang Xia, Lilia Ganova-Raeva, Chong-Gee Teo, 
Anna Lok, and Yury Khudyakov
Convergence and Coevolution of Hepatitis B Virus  
Drug Resistance
Nature Communications 2012; doi: 10.1038/ncomms1794
One way germs begin to resist drugs is through gene mutations. 
However, with hepatitis B, the usual genetic mutation may not always 
be found in resistant strains. The authors discovered that an interaction 
among sites across the entire hepatitis B genome—not just the 
rtM204I/V mutation—could produce drug resistance among the patients 
investigated. 
⧿
Michael B. Townsend, Mary S. Keckler, Nishi Patel, Dele H. Davies,  
P. Felgner, Inger K. Damon, and Kevin L. Karem
Humoral Immunity to Smallpox Vaccines and Monkeypox 
Virus Challenge; Proteomic 4 Assessment and Clinical 
Correlations
Journal of Virology 2012; doi: 10.1128/JVI.02089-12
Early smallpox vaccines caused numerous adverse reactions, leading 
to the development of new, safer vaccines. This is the first study to 
carefully define smallpox vaccine and systemic orthopoxvirus antibody 
responses to individual virus proteins. The findings show similarities 
between vaccine response in prairie dogs and humans, enhancing the 
value of the prairie dog as a vaccination model for orthopoxvirus.
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Prevention and Control
Taiwo O. Abimbola, Barbara J. Marston, Anand A. Date,  
John M. Blandford, Nalinee Sangrujee, and Stefan Z. Wiktor
Cost-Effectiveness of Tuberculosis Diagnostic Strategies to 
Reduce Early Mortality among Persons with Advanced HIV 
Infection Initiating Antiretroviral Therapy
Journal of Acquired Immune Deficiency Syndrome 2012;60(1):e1–e7
This is the first study to examine the cost-effectiveness of tuberculosis 
diagnoses among persons with advanced immunosuppressive diseases, 
such as AIDS. This is also the first paper to assess a new molecular 
diagnostic tool in reducing the mortality in this population as well as its 
cost effectiveness.
⧿
Anna Bowen, Mubina Agboatwalla, Stephen Luby, Timothy Tobery, 
Tracy Ayers, and R. M. Hoekstra
Association Between Intensive Handwashing Promotion and 
Child Development in Karachi, Pakistan
Archives of Pediatrics & Adolescent Medicine 2012;  
doi: 10.1001/archpediatrics.2012.1181
An estimated 200 million children are currently at risk for impaired 
development due to the social and environmental conditions in which 
they live. Most large-scale efforts to improve child development are 
costly and often do not reach many children. This study shows that 
children who received intensive handwashing instruction reached 
developmental milestones 6 months earlier than those who did not.
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James L. Goodson, Manisha A. Kulkarni, Jodi L. Vanden Eng,  
Kathleen A. Wannemuehler, Annett H. Cotte, Rachelle E. Desrochers, 
Bakolalao Randriamanalina, and Elizabeth T. Luman
Improved Equity in Measles Vaccination from Integrating 
Insecticide-Treated Bednets in a Vaccination Campaign, 
Madagascar
Tropical Medicine and International Health 2012;17(4):430–437
The authors analyzed vaccination coverage in a measles immunization 
campaign that included the distribution of insecticide-treated mosquito 
nets for malaria prevention. They found that pairing the mosquito 
net distribution with the immunization campaign improved measles 
vaccination coverage and mosquito net distribution among the poor. 
This approach reduced health inequities by providing protection for the 
most vulnerable children.
⧿
Edward W. Gregg, Haiying Chen, Lynne E. Wagenknecht, Jeanne M. 
Clark, Linda M. Delahanty, John Bantle, Henry J. Pownall, Karen C. 
Johnson, Monika M. Safford, Abbas E. Kitabchi, F. Xavier Pi-Sunyer, Rena 
R. Wing, and Alain G. Bertoni for the Look AHEAD Research Group
Association of an Intensive Lifestyle Intervention with 
Remission of Type 2 Diabetes
JAMA 2012;308(23):2489–2496
Type 2 diabetes has long been considered an incurable disease, with 
rare exceptions associated with bariatric surgery. This paper used data 
from the Look AHEAD study, the largest study of how life changes can 
affect cardiovascular disease among people with diabetes. It is the first 
randomized controlled trial to show that nonsurgical remission of type 2 
diabetes is possible.
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Cynthia F. Hinton, Daniel R. Neuspiel, Ruth S. Gubernick, Timothy 
Geleske, Jill Healy, Alex R. Kemper, Michele A. Lloyd-Puryear, Robert A. 
Saul, Barry H. Thompson, and Celia I. Kaye
Improving Newborn Screening Follow-Up in Pediatric 
Practices: Quality Improvement Innovation Network
Pediatrics 2012;130(3):e669–e675
The authors established a 6-month quality improvement project in 
15 primary care pediatric practices to improve short-term newborn 
screening follow-up. Practices were successful in improving their 
screening processes, and providers perceived no increase in time 
spent during each visit. Practices also increased their use of decision 
support tools after the project.
⧿
Denise J. Jamieson, Charles S. Chasela, Michael G. Hudgens, Caroline 
C. King, Athena P. Kourtis, Dumbani Kayira, Mina C. Hosseinipour, 
Deborah D. Kamwendo, Sascha R. Ellington, Jeffrey B. Wiener, Susan 
A. Fiscus, Gerald Tegha, Innocent A. Mofolo, Dorothy S. Sichali, Linda 
S. Adair, Rodney J. Knight, Francis Martinson, Zebrone Kacheche, 
Alice Soko, Irving Hoffman, and Charles van der Horst for the BAN 
Study Team
Maternal and Infant Antiretroviral Regimens to Prevent 
Postnatal HIV-1 Transmission: 48-Week Follow-Up of the BAN 
Randomised Controlled Trial
The Lancet 2012;379(9835):2449–2458
Where no safe alternative to breastfeeding exists, the World Health 
Organization recommends that antiretroviral prophylaxis be given 
to either HIV-infected mothers or infants throughout breastfeeding. 
The authors assessed the effect of 28 weeks of maternal or infant 
antiretroviral prophylaxis on postnatal HIV infection at 48 weeks.
30
Joanne Klevens, Romina Kee, William Trick, Diana Garcia,  
Francisco R. Angulo, Robin Jones, and Laura S. Sadowski
Effect of Screening for Partner Violence on  
Women’s Quality of Life 
JAMA 2012;308(7):681–689
Women who endure partner violence more often report poor physical 
and mental health. Early diagnosis and intervention could reduce 
adverse health effects. The results of this study suggest that providing 
doctors and hospitals with a partner violence resource list does not 
result in improved health outcomes. These findings provide important 
information for clinicians and others to consider in light of recent 
professional recommendations calling for routine screening.
⧿
Lara K. Misegades, Kathleen Winter, Kathleen Harriman, John Talarico, 
Nancy E. Messonnier, Thomas A. Clark, and Stacey W. Martin
Association of Childhood Pertussis with Receipt of  
5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, 
California, 2010
JAMA 2012;308(20):2126–2132
States reported more than 41,000 cases of pertussis in 2012, the most in 
the United States since 1955. Along with the emergence of pertussis in 
vaccinated school-aged children, concerns have been raised about the 
protection afforded by the pertussis vaccine series. This paper describes 
a case-control evaluation of the U.S. pertussis childhood vaccination 
program conducted during the 2010 California epidemic.
⧿
John D. Noti, William G. Lindsley, Francoise M. Blachere, Gang Cao, 
Michael L. Kashon, Robert E. Thewlis, Cynthia M. McMillen, William P. 
King, Jonathan V. Szalajda, and Donald H. Beezhold
Detection of Infectious Influenza Virus in Cough Aerosols 
Generated in a Simulated Patient Examination Room
Clinical Infectious Diseases 2012;54(11):1569–1577
The potential for influenza to be spread through breathing remains 
controversial. Clinical data have not resolved uncertainty about the 
importance of this route and the need to use N95 respirators to prevent 
it. This study shows that respirators can block the virus and that the 
influenza virus remains infectious in cough-generated air particles, 
supporting the use of N95 respirators for protection against airborne 
influenza.
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Ryan T. Novak, Jean Ludovic Kambou, Fabien V. K. Diomandé,  
Tiga F. Tarbangdo, Rasmata Ouédraogo-Traoré, Lassana Sangaré, 
Clement Lingani, Stacey W. Martin, Cynthia Hatcher, Leonard W. Mayer, 
F. Marc LaForce, Fenella Avokey, Mamoudou H. Djingarey,  
Nancy E. Messonnier, Sylvestre R. Tiendrébéogo, and Thomas A. Clark
Serogroup A Meningococcal Conjugate Vaccination in  
Burkina Faso: Analysis of National Surveillance Data
The Lancet Infectious Diseases 2012;12(10):757–764
Meningitis has posed a recurrent threat for more than 100 years for 
the 430 million people living in a sub-Saharan region of Africa known 
as the “meningitis belt.” In 2010, Burkina Faso vaccinated 11.6 million 
young people against meningitis in 11 days. To evaluate the impact of 
this campaign, the authors used national surveillance data and provided 
the first evidence of the effectiveness of this new vaccine.
⧿
John J. Sammarco, S. Gallagher, Alan Mayton, and Justin R. Srednicki
A Visual Warning System to Reduce Struck-By or Pinning 
Accidents Involving Mobile Mining Equipment
Applied Ergonomics 2012;43(6):1058–1065
The study shows that a visual warning system can prevent mine worker 
injury or death from pinning and striking accidents involving moving 
mining equipment. The experiment demonstrates that the system can 
reduce fatalities and injuries because it can be installed on any type of 
mining equipment or vehicle, above or below surfaces, and regardless 
of the commodity being mined. The system can also be adapted for 
transportation, construction, and agriculture. 
⧿
Parminder S. Suchdev, Laird J. Ruth, Bradley A. Woodruff, Charles 
Mbakaya, Usha Mandava, Rafael Flores-Ayala, Maria Elena D. Jefferds, 
and Robert Quick
Selling Sprinkles Micronutrient Powder Reduces Anemia, Iron 
Deficiency, and Vitamin A Deficiency in Young Children in 
Western Kenya: A Cluster-Randomized Controlled Trial
The American Journal of Clinical Nutrition 2012;95(5):1223–1230
This was the first study to show the effectiveness of micronutrient 
powders to prevent malnutrition. Although the value of such powders 
in reducing anemia rates has been shown, their effectiveness in 
real-world programs has not been assessed. The authors found 
significant reductions in iron deficiency and vitamin A deficiency and 
improvements in anemia cure rates among children in communities 
where the powders were promoted.
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Stephen J. Swanson, Christina R. Phares, Blain Mamo, Kirk E. Smith, 
Martin S. Cetron, and William M. Stauffer
Albendazole Therapy and Enteric Parasites in  
United States-Bound Refugees
The New England Journal of Medicine 2012;366(16):1498–1507
The authors found a 77% reduction in the rate of intestinal parasites 
among more than 26,000 refugees from sub-Saharan Africa and 
Southeast Asia between 1993 and 2007. This paper supports the 
continued use of albendazole therapy and offers insights about specific 
intestinal worms and protozoa that infect children and adults in 
resource-poor countries.
⧿
Michael C. Thigpen, Poloko M. Kebaabetswe, Lynn A. Paxton, Dawn 
K. Smith, Charles E. Rose, Tebogo M. Segolodi, Faith L. Henderson, 
Sonal R. Pathak, Fatma A. Soud, Kata L. Chillag, Rodreck Mutanhaurwa, 
Lovemore Ian Chirwa, Michael Kasonde, Daniel Abebe, Evans Buliva, 
Roman J. Gvetadze, Sandra Johnson, Thom Sukalac, Vasavi T. Thomas, 
Clyde Hart, Jeffrey A. Johnson, C. Kevin Malotte, Craig W. Hendrix, and 
John T. Brooks for the TDF2 Study Group
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV 
Transmission in Botswana
The New England Journal of Medicine 2012;367(5):423–434
Preexposure prophylaxis (PrEP) with antiretroviral drugs has been 
shown to reduce the spread of HIV among men who have sex with 
men, but the effectiveness among heterosexuals is uncertain. These 
are the first data to quantify the efficacy of PrEP for the prevention of 
HIV transmission among heterosexuals. The findings have led several 
African countries to consider PrEP as a national strategy to prevent HIV 




The following current or former CDC/ATSDR employees were nominated 
for the Lifetime Scientific Achievement Award, which recognizes 
individuals for a body of work contributing to public health.  
Nominees were judged on their work’s scientific merit, its effect on  
public health and the mission of CDC/ATSDR, and on their  
leadership and recognition by peers.
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Larry J. Anderson, MD 
National Center for Immunization and Respiratory Diseases 
Dr. Larry Anderson’s research has focused on respiratory syncytial 
virus (RSV) and the assessment of its disease burden the United States, 
which is responsible for more than 10,000 deaths each year. His 
research has led to the development of widely used reference reagents, 
research agreements to develop reagents for laboratories, and a series 
of patents on inventions concerning disease progression and immunity 
mechanisms of RSV.
Dr. Anderson has consistently applied methods from various specialties, 
and he has developed new ways to resolve public health problems. 
He holds six patents in viral diagnostics, immune modulation, and 
immunization. In 1999, he led an interdisciplinary team of scientists that 
performed the initial genetic characterization of Nipah virus following 
its emergence in Malaysia and Singapore. He supervised some of the 
first studies on Nipah virus and went on to characterize infections in 
Bangladesh and India in later years. In 2003, he led efforts that resulted 
in the discovery and molecular characterization of a novel emergent 
coronavirus responsible for the SARS pandemic. Through his leadership 
of CDC’s response, assays were developed and deployed domestically 
for surveillance, and scientific studies were conducted that led to 
a better understanding of SARS epidemiology, clinical disease, and 
distribution of related coronaviruses. 
Dr. Anderson’s expertise in public health, virology, and epidemiology 
also led to his accepting an assignment in the Department of Health 
and Human Services as a senior scientist to develop a strategy for 
smallpox vaccination. His leadership and accomplishments have made 
him an internationally recognized expert in the field of infectious 
diseases. He is an author of more than 200 peer-reviewed scientific 
publications and 56 book chapters and reviews. His direct supervision 
of research teams has resulted in more than 130 peer-reviewed 
publications with his colleagues. His influence and contributions to the 
scientific activities of other work groups inside and outside his area of 
responsibility resulted in about 100 more peer-reviewed publications. 
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Hani K. Atrash, MD, MPH
National Center on Birth Defects and Developmental Disabilities 
Since graduating from medical school at the American University of 
Beirut in 1975, Dr. Hani Atrash has focused his career on maternal 
and child health. He has served in a variety of capacities at CDC since 
1979, when he joined the Epidemic Intelligence Service in the Family 
Planning Evaluation Division. 
Dr. Atrash is noted for establishing a national agenda to provide 
women and families with preconception health services, domestically 
and internationally. He convened the first national summit on 
preconception care in June 2005. The summit was cosponsored by 35 
national organizations and 5 federal agencies and resulted in consensus 
recommendations. 
As a result of Dr. Atrash’s leadership, preconception health promotion 
is now recognized as critical in both domestic and international 
maternal and child health programs. Domestically, 47 states now have 
preconception health indicators in state performance measures and 
priority needs. As a result of his work, the lives of millions of women, 
children, and families around the world have been improved. This 
achievement is shown by the World Health Organization’s efforts to 
ensure all women of reproductive age receive preconception counseling. 
Dr. Atrash has served as a role model and motivated others to pursue 
excellence in scientific quality and productivity. His original scientific 
and scholarly contributions are quite impressive, having authored or 
coauthored more than 150 journal articles and book chapters. 
Dr. Atrash’s international leadership is reflected by the breadth of 
awards for which he has been nominated or has received, including 
the American Public Health Association’s Distinguished Service 
Award for Maternal Child Health, the CDC/ATSDR William C. Watson 
Medal of Excellence, the Federal Employee of the Year Award for 
Outstanding Manager, the Nathan Davis Government Service Award, 
and the Service to America Award. He was noted in a peer-reviewed 
journal to have the most diverse staff of epidemiologists in the United 
States and perhaps in the world. 
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Robert A. Hahn, PhD, MPH
Office of Surveillance, Epidemiology, and Labratory Services 
Dr. Robert Hahn has been a pioneer in bridging the disciplines 
of anthropology, epidemiology, and public health. His desire to 
improve the health of poor and minority populations brought 
him to CDC, where he has focused on promoting health equity; 
integrating disciplines to tackle public health problems; and improving 
measurement, analysis, and data interpretation—all critical to improving 
the nation’s health. 
Because of his research, Dr. Hahn was asked to represent CDC in the 
revision of racial and ethnic classifications for U.S. census statistics, a 
process that lasted several years, resulting in a new directive published 
in 1997 and providing classifications for the 2000 census. His research 
on classification continued and has yielded an extensive examination 
and critique of health statistics on racial and ethnic populations in the 
United States. 
From the beginning of his CDC career, he has used his knowledge of 
epidemiology and anthropology to show how anthropology could play 
a prominent role in population health. He wrote Sickness and Healing; 
An Anthropological Perspective in his spare time. As part of his work at 
CDC, he edited the anthology, Anthropology in Public Health: Bridging 
Differences in Culture and Society, which shows how anthropology 
often clarifies public health issues, provides methods for analysis, and 
enhances public health practice. 
In 1998, Dr. Hahn was elected to the Senior Biomedical Research 
Service, an elite employment track in the Public Health Service used to 
recruit and retain widely recognized scientific leaders. He is the only 
anthropologist in this group at CDC. In 2007, Dr. Hahn won CDC’s 
National Center for Health Marketing Scientist of the Year Award for 
his Community Guide systematic reviews on public policy. He has also 
won two individual and one unit Commissioned Corps Commendation 
awards. In December 2012, the Society for Medical Anthropology 
presented its Career Achievement Award to Dr. Hahn. 
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Albert E. Munson, PhD
National Institute for Occupational Safety and Health
For 43 years, Dr. Albert Munson has been a pioneer in the field of 
immunotoxicology. In fact, he is viewed as one of the discipline’s 
founding fathers. Dr. Munson brought his scientific leadership to the 
National Institute of Occupational Safety and Health (NIOSH) in 1997. 
Beginning with a tiny staff, he led the establishment of the Health 
Effects Laboratory Division, now comprising more than 200 staff 
dedicated to explaining the causes and mechanisms of occupational 
diseases. He also developed liaisons and partnerships with the 
National Toxicology Program and National Institute of Environmental 
Health Sciences, integrating missions across agencies and providing 
competencies and services to the Department of Health and Human 
Services’ wider public health mission.
Dr. Munson established a highly successful basic science division within 
NIOSH, integrated its mission to public health practice and prevention, 
and eased the transfer of infrastructure activities to NIOSH and CDC. 
He has continued the tradition of Dr. Shepard by translating laboratory 
research into action relevant to CDC’s public health mission.
Dr. Munson has published more than 270 peer-reviewed journal articles, 
proceeding reports, and book chapters, and served on 18 professional 
organizations, including current service in the Society of Toxicology, 
the American Society for Pharmacology and Experimental Therapeutics, 
and the American Cancer Society. He has served as a reviewer for 24 
scientific journals, on the editorial boards of 7 journals, and as a mentor 
to 25 PhD students.
The success of his scientific leadership of the Health Effects 
Laboratory Division is seen in the number of division scientists who 
serve on national and international advisory committees; numerous 
division alumni in scientific positions in academia, government 
agencies, and industry; and 22 patents by division staff. The 
contributions of division research to Occupational Safety and Health 
Administration regulations, American Society for Testing Materials 
standards, and NIOSH policy documents—and the production of 
data to address emerging workplace issues—also demonstrate his 
influence. Division scientists are sought by science investigators 
around the world to be co-investigators on grant submissions. 
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Govinda Visvesvara, PhD
National Center for Emerging and Zoonotic Infectious Diseases
During the past 40 years, Dr. Govinda Visvesvara has established 
himself as the preeminent authority on free-living amebic infections in 
humans, specializing in the biology and diagnostics of these organisms 
and the often fatal infections they cause. Dr. Visvesvara set up CDC’s 
Free-Living Amebas (FLA) Laboratory and paved the scientific path 
for studying free-living amebic infections. His diagnostic methods for 
free-living amebas have become standard around the world. During 
his tenure at CDC, he has increased awareness and understanding of 
free-living amebic infections, resulting in increased reporting of these 
illnesses and increased interest in drug testing, genomic sequencing, 
pathogenicity, epidemiology, and environmental microbiology.
Dr. Visvesvara discovered, named, and has continued to document the 
pathogenicity of Balamuthia mandrillaris. He developed diagnostic 
immunofluorescence methods and has recently developed a way to 
more rapidly screen investigation samples. He was the first to identify 
Balamuthia as a transplant-associated infection and has been involved 
in investigations of three transplant clusters.
The CDC Free-Living Ameba Laboratory is one of the “CDC Gems” that 
has supported further research on these rare but severe diseases (for 40 
years). Increased detection and changing epidemiology underscore the 
role these national laboratories have in supporting health professionals. 
The free-living ameba “voice in the wilderness” that Dr. Visvesvara once 
was, has been heard, and CDC has developed a balanced program to 
prevent these tragic infections. 
Dr. Visvesvara is a renowned leader in his field. He has written more 
than 40 book chapters and reviews on FLA, as well as more than 300 
scientific papers. He has been invited to give talks around the world, 
and he has served as a reviewer for 14 journals and four federal 
agencies and foundations. Perhaps the ultimate honor from his peers 







Concepción F. Estívariz, Hamid Jafari, Roland W. Sutter, T. Jacob John, 
Vibhor Jain, Ashutosh Agarwal, Harish Verma, Mark A Pallansch, Ajit P. 
Singh, Sherine Guirguis, Jitendra Awale, Anthony Burton, Sunil Bahl, 
Arani Chatterjee, and R. Bruce Aylward
Immunogenicity of Supplemental Doses of Poliovirus Vaccine 
for Children Aged 6–9 Months in Moradabad, India:  
A Community-Based, Randomized Controlled Trial
The Lancet Infectious Diseases 2012;12(2):128–135 (published  
online 2011)
Laboratory Science
Brian H. Bird, Louis H. Maartens, Shelley Campbell, Baltus J. Erasmus, 
Bobbie R. Erickson, Kimberly A. Dodd, Christina F. Spiropoulou, 
Deborah Cannon, Clifton P. Drew, Barbara Knust, Anita K. McElroy, 
Marina L. Khristova, César G. Albariño, and Stuart T. Nichol
Rift Valley Fever Virus Vaccine Lacking the NSs and NSm 
Genes is Safe,  Nonteratogenic, and Confers Protection from 
Virema, Pyrexia, and Abortion following Challenge in Adult 
and Pregnant Sheep
Journal of Virology 2011; 85(24):12901–12909
Prevention and Control
Timothy R. Sterling, M. Elsa Villarino, Andrey S. Borisov, Nong Shang, 
Fred Gordin, Erin Bliven-Sizemore, Judith Hackman, Carol Dukes 
Hamilton, Dick Menzies, Amy Kerrigan, Stephen E. Weis, Marc Weiner, 
Diane Wing, Marcus B. Conde, Lorna Bozeman, C. Robert Horsburgh, 
and Richard E. Chaisson for the TB Trials Consortium PREVENT TB 
Study Team
Three Months of Rifapentine and Isoniazid for Latent 
Tuberculosis Infection 
The New England Journal of Medicine 2011;365(23):2155–2166
40
Data Methods and Study Design 
Alula Hadgu, Nandini Dendukuri, and Liangliang Wang
Evaluation of Screening Tests for Detecting Chlamydia 
trachomatis: Bias Associated with the Patient-Infected-Status
Algorithm Epidemiology 2012;23(1):72–82 (published online 2011)
Lifetime Scientific Achievement
Henry Falk, MD, MPH
Dr. Falk was recognized for his leadership and his efforts to bring the 




Stacy M. Holzbauer, Aaron S. DeVries, James J. Sejvar, Christine H. Lees, 
Jennifer Adjemian, Jennifer H. McQuiston, Carlota Medus, Catherine 
A. Lexau, Julie R. Harris, Sergio E. Recuenco, Ermias D. Belay, James F. 
Howell, Bryan F. Buss, Mady Hornig, John D. Gibbins, Scott E. Brueck, 
Kirk E. Smith, Richard N. Danila, W. Ian Lipkin, Daniel H. Lachance,  
P. James B. Dyck, and Ruth Lynfield 
Epidemiologic Investigation of Immune-Mediated 
Polyradiculoneuropathy among Abattoir Workers Exposed  
to Porcine Brain 
PLoS One 2010;5(3):e9782
Laboratory and Methods
Robert D. Gilmore, Jr., Rebekah R. Howison, Gabrielle Dietrich, Toni G. 
Patton, Dawn R. Clifton, and James A. Carroll
The bba64 Gene of Borrelia burgdorferi, the Lyme Disease 
Agent, is Critical for Mammalian Infection via Tick Bite 
Transmission




Charles S. Chasela, Michael G. Hudgens, Denise J. Jamieson, Dumbani 
Kayira, Mina C. Hosseinipour, Athena P. Kourtis, Francis Martinson, 
Gerald Tegha, Rodney J. Knight, Yusuf I. Ahmed, Deborah D. 
Kamwendo, Irving F. Hoffman, Sascha R. Ellington, Zebrone Kacheche, 
Alice Soko, Jeffrey B. Wiener, Susan A. Fiscus, Peter Kazembe, 
Innocent A. Mofolo, Maggie Chigwenembe, Dorothy S. Sichali, and 
Charles M. van der Horst for the Breastfeeding, Antiretroviral, and 
Nutrition Study Group 
Maternal or Infant Antiretroviral Drugs to Reduce  
HIV-1 Transmission 
The New England Journal of Medicine 2010;362(24):2271–2281
Lifetime Scientific Achievement
Kathleen Kreiss, MD
Dr. Kreiss was recognized as a world-renowned expert in occupational 
respiratory disease. She has improved workplace safety by encouraging 
the use of safer materials and better work practices and controls. 
2010
Assessment and Epidemiology
Fatimah S. Dawood, Seema Jain, Lyn Finelli, Michael W. Shaw, Stephen 
Lindstrom, Rebecca J. Garten, Larisa V. Gubareva, Xiyan Xu, Carolyn B. 
Bridges, and Timothy M. Uyeki
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus 
in Humans
The New England Journal of Medicine 2009;360:2605–2615
Laboratory and Methods
Joseph U. Igietseme, Qing He, Kahaliah Joseph, Francis O. Eko, 
Deborah Lyn, Godwin Ananaba, Angela Campbell, Claudiu Bandea,  
and Carolyn M. Black
Role of T Lymphocytes in the Pathogenesis of  
Chlamydia Disease
The Journal of Infectious Diseases 2009;200:926–934
42
Prevention and Control (Two Awards)
Sandra L. Decker
Changes in Medicaid Physician Fees and Patterns of 
Ambulatory Care
Inquiry 2009;46(3)291–304
Manish Patel, Cristina Pedreira, Lucia Helena De Oliveira, Jacqueline 
Tate, Maribel Orozco, Juan Mercado, Alcides Gonzalez, Omar Malespin, 
Juan José Amador, Jazmina Umaña, Angel Balmaseda, Maria  
Celina Perez, Jon Gentsch, Tara Kerin, Jennifer Hull, Slavica Mijatovic, 
Jon Andrus, and Umesh Parashar 
Association between Pentavalent Rotavirus Vaccine and 
Severe Rotavirus Diarrhea among Children in Nicaragua 
JAMA 2009;301(21):2243–2251
Lifetime Scientific Achievement
Polly Marchbanks, PhD, MSN
Dr. Marchbanks was recognized for her global leadership and research, 
particularly in the area of contraception.
2009
Assessment and Epidemiology
H. Irene Hall, Ruiguang Song, Philip Rhodes, Joseph Prejean, Qian An, 
Lisa M. Lee, John Karon, Ron Brookmeyer, Edward H. Kaplan, Matthew 
T. McKenna, and Robert S. Janssen for the HIV Incidence Surveillance 
Group
Estimation of HIV Incidence in the United States
JAMA 2008;300:520–529
Laboratory and Methods
Tracie L. Williams, Leah Luna, Zhu Guo, Nancy J. Cox, James L. Pirkle, 
Ruben O. Donis, and John R. Barr
Quantification of Influenza Virus Hemagglutinins in Complex 




Larissa Roux, Michael Pratt, Tammy O. Tengs, Michelle M. Yore,  
Teri L. Yanagawa, Jill Van Den Bos, Candace Rutt, Ross C. Brownson, 
Kenneth E. Powell, Gregory Heath, Harold W. Kohl III, Steven Teutsch, 
John Cawley, I-Min Lee, Linda West, and David M. Buchner
Cost Effectiveness of Community-Based Physical Activity 
Interventions
American Journal of Preventive Medicine 2008;35:578–588
Lifetime Scientific Achievement
Stephen B. Thacker, MD, MSc
Dr. Thacker was recognized for his leadership and his work in fostering 
scientific communication and training of future leaders in public health. 
He has overseen the EIS program since 1989, and under his direction, 
the first CDC plan for surveillance was completed in 1985.
2008
Assessment and Epidemiology
Earl S. Ford, Umed A. Ajani, Janet B. Croft, Julia A. Critchley, Darwin R. 
Labarthe, Thomas E. Kottke, Wayne H. Giles, and Simon Capewell
Explaining the Decrease in U.S. Deaths from Coronary 
Disease, 1980–2000
The New England Journal of Medicine 2007;356:2388–2398
Laboratory and Methods
Terrence M. Tumpey, Christopher F. Basler, Patricia V. Aguilar, Hui Zeng, 
Alicia Solórzano, David E. Swayne, Nancy J. Cox, Jacqueline M. Katz, 
Jeffery K. Taubenberger, Peter Palese, and Adolfo García-Sastre
A Two-Amino Acid Change in the Hemagglutinin of the 1918 
Influenza Virus Abolishes Transmission
Science 2007;315:655–659
Prevention and Control
R. Louise Floyd, Mark Sobell, Mary M. Velasquez, Karen Ingersoll, Mary 
Nettleman, Linda Sobell, Patricia Dolan Mullen, Sherry Ceperich, Kirk 
von Sternberg, Burt Bolton, Bradley Skarpness, and Jyothi Nagaraja on 
behalf of the Project CHOICES Efficacy Study Group
Preventing Alcohol-Exposed Pregnancies: A Randomized 
Controlled Trial




Dr. Castranova was recognized for his leadership in laboratory-based 
occupational health research. His contributions to the understanding of 
the biology of lung cells have been translated into the practical study of 
lung diseases and development of prevention programs.
2007
Assessment and Epidemiology
Wolfgang Hladik, Shelia C. Dollard, Jonathan Mermin, Ashley L. 
Fowlkes, Robert Downing, Minal M. Amin, Flora Banage, Esau Nzaro, 
Peter Kataaha, Timothy J. Dondero, Philip E. Pellett, and Eve M. Lackritz
Transmission of Human Herpesvirus 8 by Blood Transfusion
The New England Journal of Medicine 2006;355:1331–1338
Laboratory and Methods
Mary A. Hoelscher, Sanjay Garg, Dinesh S. Bangari, Jessica A. Belser, 
Xiuhua Lu, Iain Stephenson, Rick A. Bright, Jacqueline M. Katz, Suresh 
K. Mittal, and Suryaprakash Sambhara
Development of Adenoviral-Vector-Based Pandemic Influenza 




Cynthia G. Whitney, Tamar Pilishvili, Monica M. Farley, William 
Schaffner, Allen S. Craig, Ruth Lynfield, Ann-Christine Nyquist, Kenneth 
A. Gershman, Marietta Vazquez, Nancy M. Bennett, Arthur Reingold, 
Ann Thomas, Mary P. Glode, Elizabeth R. Zell, James H. Jorgensen, 
Bernard Beall, and Anne Schuchat
Effectiveness of Seven-Valent Pneumococcal Conjugate 





Roger I. Glass, MD, PhD, MPH
Dr. Glass was recognized for his leadership and accomplishments in 
viral gastroenteritis. His work led to the recognition of rotavirus as a 
problem in the United States and to development of a rotavirus vaccine 
to be used worldwide.
2006
Assessment and Epidemiology
Lee Warner, Maurizio Macaluso, Harland D. Austin, David K. Kleinbaum, 
Lynn Artz, Michael E. Fleenor, Ilene Brill, Daniel R. Newman, and 
Edward W. Hook III
Application of the Case-Crossover Design to Reduce 
Unmeasured Confounding in Studies of Condom Effectiveness
American Journal of Epidemiology 2005;161:765–773
Laboratory and Methods
Terrence M. Tumpey, Christopher F. Basler, Patricia V. Aguilar,  
Hui Zeng, Alicia Solórzano, David E. Swayne, Nancy J. Cox, Jacqueline 
M. Katz, Jeffery K. Taubenberger, Peter Palese, and Adolfo García-Sastre




Stephen P. Luby, Mubina Agboatwalla, Daniel R. Feikin, John Painter, 
Ward Billhimer, Arshad Altaf, and Robert M. Hoekstra




Robert V. Tauxe, MD, MPH
Dr. Tauxe was recognized for his leadership in the prevention and 
control of foodborne diseases in the United States and internationally. 
His work and that of his colleagues has resulted in dramatic changes 





Barbara Lopes Cardozo, Oleg O. Bilukha, Carol A. Gotway Crawford, 
Irshad Shaikh, Mitchell I. Wolfe, Michael L. Gerber, and Mark Anderson




Justin M. Hettick, Michael L. Kashon, Janet P. Simpson,  
Paul D. Siegel, Gerald H. Mazurek, and David N. Weissman
Proteomic Profiling of Intact Mycobacteria by Matrix-




Marc Bulterys, Denise J. Jamieson, Mary Jo O’Sullivan, Mardge H. 
Cohen, Robert Maupin, Steven Nesheim, Mayris P. Webber, Russell Van 
Dyke, Jeffrey Wiener, and Bernard M. Branson for the Mother-Infant 
Rapid Intervention at Delivery Study Group
Rapid HIV-1 Testing during Labor: A Multicenter Study
JAMA 2004;292:219–223
Outstanding Scientific Contribution to Public Health  
Newborn Screening Quality Assurance Program 
National Center for Environmental Health/Agency for 
Toxic Substances and Disease Registry 
William H. Hannon, Barbara W. Adams, and Robert F. Vogt
Lifetime Scientific Achievement
James M. Hughes, MD
Dr. Hughes was recognized for his expertise in infectious diseases and 
bioterrorism and response. His leadership in addressing emerging and 
re-emerging global threats has brought global prominence to CDC and 




Jennita Reefhuis, Margaret A. Honein, Cynthia G. Whitney, Shadi 
Chamany, Eric A. Mann, Krista R. Biernath, Karen Broder, Susan 
Manning, Swati Avashia, Marcia Victor, Pamela Costa, Owen Devine,  
Ann Graham, and Coleen Boyle
Risk of Bacterial Meningitis in Children with  
Cochlear Implants
The New England Journal of Medicine 2003;349:435–445
Laboratory and Methods
Thomas G. Ksiazek, Dean Erdman, Cynthia S. Goldsmith, Sherif R. 
Zaki, Teresa Peret, Shannon Emery, Suxiang Tong, Carlo Urbani, James 
A. Comer, Wilina Lim, Pierre E. Rollin, Scott F. Dowell, Ai-Ee Ling, 
Charles D. Humphrey, Wun-Ju Shieh, Jeannette Guarner, Christopher D. 
Paddock, Paul Rota, Barry Fields, Joseph DeRisi, Jyh-Yuan Yang, Nancy 
Cox, James M. Hughes, James W. LeDuc, William J. Bellini, Larry J. 
Anderson, and the SARS Working Group
A Novel Coronavirus Associated with Severe Acute 
Respiratory Syndrome
The New England Journal of Medicine 2003;348:1953–1966
Prevention and Control
Cynthia G. Whitney, Monica M. Farley, James Hadler, Lee H. Harrison, 
Nancy M. Bennett, Ruth Lynfield, Arthur Reingold, Paul R. Cieslak, 
Tamara Pilishvili, Delois Jackson, Richard R. Facklam, James H. 
Jorgensen, and Anne Schuchat for the Active Bacterial Core Surveillance 
of the Emerging Infections Program Network
Decline in Invasive Pneumococcal Disease after the 
Introduction of Protein-Polysaccharide Conjugate Vaccine
The New England Journal of Medicine 2003;348:1737–1746
Lifetime Scientific Achievement (Two Awards)
Harold W. Jaffe, MD
Dr. Jaffe was recognized as a national and international leader in the 
disease investigation of HIV/AIDS, which has increased scientific 
knowledge about HIV/AIDS and affected national and international 
approaches to prevention and control.
48
Walter A. Orenstein, MD
Dr. Orenstein was recognized for his leadership in reducing the 
occurrence of vaccine-preventable diseases in children. His work has 




Polly A. Marchbanks, Jill A. McDonald, Hoyt G. Wilson, Suzanne G. 
Folger, Michele G. Mandel, Janet R. Daling, Leslie Bernstein, Kathleen E. 
Malone, Giske Ursin, Brian L. Strom, Sandra A. Norman, Linda K. Weiss, 
Phyllis Wingo, Michael S. Simon, Ronald T. Burkman, Jesse A. Berlin, 
and Robert Spirtas
Oral Contraceptives and the Risk of Breast Cancer
The New England Journal of Medicine 2002;346:2025–2032
Laboratory and Methods
Bharat S. Parekh, M. Susan Kennedy, Trudy Dobbs, Chou-Pong Pau, 
Robert Byers, Timothy Green, Dale J. Hu, Suphak Vanichseni,  
Nancy L. Young, Kachit Choopanya, Timothy D. Mastro, and  
J. Steven McDougal
Quantitative Detection of Increasing HIV Type 1 Antibodies 
after Seroconversion: A Simple Assay for Detecting Recent 
HIV Infection and Estimating Incidence
AIDS Research and Human Retroviruses 2002;18:295–307
Prevention and Control
Robert E. Quick, Akiko C. Kimura, Angelica Thevos, Mathias Tembo, 
Isidore Shamputa, Lori Hutwagner, and Eric Mintz
Diarrhea Prevention through Household-Level Water 
Disinfection and Safe Storage in Zambia
The American Journal of Tropical Medicine and Hygiene  
2002;66:584–589
Outstanding Scientific Contribution to Public Health
Barbara Lopes Cardozo, Bradley A. Woodruff, Muireann Brennan, and 
Paul B. Spiegel
International Emergency and Refugee Health Branch 
National Center for Environmental Health
49
Lifetime Scientific Achievement
William R. Jarvis, MD
Dr. Jarvis was recognized as a leader in the study of nosocomial 
infections and other threats to the safety of patients and health care 
workers. His research has led to interventions to reduce these risks and 
to the development of prevention guidelines.
2002
Assessment and Epidemiology
Trudy V. Murphy, Paul M. Gargiulio, Mehran S. Massoudi, David B. 
Nelson, Aisha O. Jumaan, Catherine A. Okoro, Lynn R. Zanardi, Sabeena 
Setia, Elizabeth Fair, Charles W. LeBaron, Melinda Wharton, John R. 
Livengood, and Benjamin Schwartz, for the Rotavirus Intussusception 
Inspection Team
Intussusception among Infants Given an Oral Rotavirus 
Vaccine
The New England Journal of Medicine 2001;344:564–572
Laboratory and Methods
Brent S. Davis, Gwong-Jen J. Chang, Bruce Cropp, John T. Roehrig, 
Denise A. Martin, Carl J. Mitchell, Richard Bowen, and Michel L. 
Bunning
West Nile Virus Recombinant DNA Vaccine Protects Mouse 
and Horse from Virus Challenge and Expresses in vitro a 
Noninfectious Recombinant Antigen That Can Be Used in 
Enzyme-Linked Immunosorbent Assays 
Journal of Virology 2001;75:4040–4047
Prevention and Control
Belinda E. Ostrowsky, William E. Trick, Annette H. Sohn, Stephen 
B. Quirk, Stacey Holt, Loretta A. Carson, Bertha C. Hill, Matthew J. 
Arduino, Matthew J. Kuehnert, and William R. Jarvis
Control of Vancomycin-Resistant Enterococcus in  
Health Care Facilities in a Region
The New England Journal of Medicine 2001;344:1427–1433
50
Outstanding Scientific Contribution to Public Health
Ronald M. Davis, Gary A. Giovino, Michael D. Erikson, and the  
Office on Smoking and Health 
Surgeon General’s Reports on Smoking and Health National 
Center for Chronic Disease Prevention and Health Promotion
Lifetime Scientific Achievement
Gerald R. Cooper, MD, PhD
Dr. Cooper was recognized for his leadership in improving laboratory 




Paul B. Spiegel and Peter Salama




K.B. Chua, William J. Bellini, Paul A. Rota, Brian H. Harcourt, Azaibi 
Tamin, S.K. Lam, Thomas G. Ksiazek, Pierre E. Rollin, Sherif R. Zaki, 
Wun-Ju Shieh, Cynthia S. Goldsmith, Duane J. Gubler, John T. Roehrig, 
B. Eaton, A.R. Gould, Jim Olson, H. Field, P. Daniels, A.E. Ling, Clarence 
J. Peters, Larry J. Anderson, and Brian W.J. Mahy
Nipah Virus: A Recently Emergent Deadly Paramyxovirus
Science 2000;288:1432–1435
Prevention and Control
Carolyn Buxton Bridges, William W. Thompson, Martin I. Meltzer, 
Gordon R. Reeve, Walter J. Talamonti, Nancy J. Cox, Heather A. Lilac, 
Henrietta Hall, Alexander Klimov, and Keiji Fukuda
Effectiveness and Cost-Benefit of Influenza Vaccination of 
Healthy Working Adults: A Randomized Controlled Trial
JAMA 2000;284:1655–1662
Outstanding Scientific Contribution to Public Health  
(Two Awards)
Behavioral Risk Factor Surveillance System




Joseph Edward McDade, PhD
Dr. McDade was the first to identify the bacterium Legionella 
pneumophila as the cause of the well-known outbreak of Legionnaires’ 




Nathan Shaffer, Rutt Chuachoowong, Philip A. Mock, Chaiporn 
Bhadrakom, Wimol Siriwasin, Nancy L. Young, Tawee 
Chotpitayasunondh, Sanay Chearskul, Anuvant Roongpisuthipong, 
Pratharn Chinayon, John Karon, Timothy D. Mastro, and R.J. Simonds
Short-Course Zidovudine for Perinatal HIV-1 Transmission in 
Bangkok, Thailand: A Randomised Controlled Trial
The Lancet 1999;353:773–780
1999
Robert S. Janssen, Glen A. Satten, Susan L. Stramer, Bhupat D. Rawal, 
Thomas R. O’Brien, Barbara J. Weiblen, Frederick M. Hecht, Noreen 
Jack, Farley R. Cleghorn, James O. Kahn, Margaret A. Chesney, and 
Michael P. Busch
New Testing Strategy to Detect Early HIV-1 Infection for 




Denise M. Cardo, David H. Culver, Carol A. Ciesielski, Pamela U. 
Srivastava, Ruthanne Marcus, Dominique Abiteboul, Julia Heptonstall, 
Giuseppe Ippolito, Florence Lot, Penny S. McKibben, and David M. 
Bell for the Centers for Disease Control and Prevention Needlestick 
Surveillance Group
A Case-Control Study of HIV Seroconversion in Health Care 
Workers after Percutaneous Exposure
The New England Journal of Medicine 1997;337:1485–1490
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1997 (Two Awards)
Jennifer S. Rota, Janet L. Heath, Paul A. Rota, Gail E. King, María L. 
Celma, Juan Carabaña, Rafael Fernandez-Muñoz, David Brown, Li Jin, 
and William J. Bellini
Molecular Epidemiology of Measles Virus: Identification  
of Pathways of Transmission and Implications for  
Measles Elimination
The Journal of Infectious Diseases 1996;173:32–37
Diana E. Schendel, Cynthia J. Berg, Marshalyn Yeargin-Allsopp, 
Coleen A. Boyle, and Pierre Decoufle
Prenatal Magnesium Sulfate Exposure and the Risk for 
Cerebral Palsy or Mental Retardation among Very Low-Birth-
Weight Children Aged 3 to 5 Years
JAMA 1996;276:1805–1810
1996
Peter M. Strebel, Nicolae Ion-Nedelcu, Andrew L. Baughman,  
Roland W. Sutter, and Stephen L. Cochi
Intramuscular Injections within 30 Days of Immunization 
with Oral Poliovirus Vaccine—A Risk Factor for Vaccine-
Associated Paralytic Poliomyelitis
The New England Journal of Medicine 1995;332:500–506
1995
Robert D. Brewer, Peter D. Morris, Thomas B. Cole, Stephanie Watkins, 
Michael J. Patetta, and Carol Popkin
The Risk of Dying in Alcohol-Related Automobile Crashes 
among Habitual Drunk Drivers
The New England Journal of Medicine 1994;331:513–517
1994
Michael E. St. Louis, Munkolenkole Kamenga, Christopher Brown, Ann 
Marie Nelson, Tarande Manzila, Veronique Batter, Frieda Behets, Uwa 
Kabagabo, Robert W. Ryder, Margaret Oxtoby, Thomas C. Quinn, and 
William L. Heyward
Risk for Perinatal HIV-1 Transmission According to Maternal 




Brian R. Edlin, Jerome I. Tokars, Michael H. Grieco, Jack T. Crawford, 
Julie Williams, Emelia M. Sordillo, Kenneth R. Ong, James O. Kilburn, 
Samuel W. Dooley, Kenneth G. Castro, William R. Jarvis, and  
Scott D. Holmberg
An Outbreak of Multidrug-Resistant Tuberculosis among 
Hospitalized Patients with the Acquired Immunodeficiency 
Syndrome
The New England Journal of Medicine 1992;326:1514–1521
1992
Marta Gwinn, Marguerite Pappaioanou, J. Richard George, W. Harry 
Hannon, Shari C. Wasser, Martha A. Redus, Rodney Hoff, George F. 
Grady, Anne Willoughby, Antonia C. Novello, Lyle R. Petersen, Timothy 
J. Dondero, and James W. Curran




Edward A. Belongia, Craig W. Hedberg, Gerald J. Gleich, Karen E. 
White, Arthur N. Mayeno, David A. Loegering, Sandra L. Dunnette, 
Phyllis L. Pirie, Kristine L. MacDonald, and Michael T. Osterholm
An Investigation of the Cause of the Eosinophilia-Myalgia 
Syndrome Associated with Tryptophan Use
The New England Journal of Medicine 1990;323:357–365
1990
Patricia M. Griffin, Robert V. Tauxe, Stephen C. Redd, Nancy D. Puhr, 
Nancy Hargrett-Bean, and Paul A. Blake
Emergence of Highly Trimethoprim-Sulfamethoxazole–
Resistant Shigella in a Native American Population: An 
Epidemiologic Study
American Journal of Epidemiology 1989;129:1042–1051
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1989
Chin-Yih Ou, Shirley Kwok, Sheila W. Mitchell, David H. Mack, John 
J. Sninsky, John W. Krebs, Paul Feorino, Donna Warfield, and Gerald 
Schochetman
DNA Amplification for Direct Detection of HIV-1 in DNA of 
Peripheral Blood Mononuclear Cells
Science 1988;239:295–297
1988
Rebeca Rico-Hesse, Mark A. Pallansch, Baldev K. Nottay, and Olen M. 
Kew
Geographic Distribution of Wild Poliovirus Type 1 Genotypes
Virology 1987;160:311–322
1987
J. Steven McDougal, M. Susan Kennedy, Julie M. Sligh, Sheila P. Cort, 
Alison C. Mawle, and Janet K. A. Nicholson
Binding of HTLV–III/LAV to T4+ T Cells by a Complex of the 
100K Viral Protein and the T4 Molecule
Science 1986;231:382–385
1986
Arthur L. Reingold, Claire V. Broome, Allen W. Hightower, Gloria W. 
Ajello, Gail A. Bolan, Catherine Adamsbaum, Ellen E. Jones, Catherine 
Phillips, Hilaire Tiendrebeogo, and Adamou Yada
Age-Specific Differences in Duration of Clinical  
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